In response: Naming and recognition after laser amygdalohippocampotomy: Is the hippocampus involved?
In response: Naming and recognition after laser amygdalohippocampotomy: Is the hippocampus involved?
复制标题
回应：激光杏仁核海马切除术后的命名和识别：海马体是否受到影响？
DOI：
10.1111/epi.13065
复制
发表时间：
2015
期刊：
影响因子：
5.6
通讯作者：
Gross,RobertE
中科院分区：
文献类型：
--
作者：
Drane,DanielL;Loring,DavidW;Voets,NatalieL;Price,Michele;Ojemann,JeffreyG;Willie,JonT;Saindane,AmitM;Phatak,Vaishali;Ivanisevic,Mirjana;Millis,Scott;Helmers,SandraL;Miller,JohnW;Meador,KimfordJ;Gross,RobertE
Drane博士已经从NIH/NINDS获得了三笔赠款，用于支持他最近在《癫痫》杂志上发表的与编辑回应这封信有关的手稿(K23 NSO49100、K02 NS070960和R01NS088748)。这些补助金为德雷恩博士和他的实验室工作人员提供了工资支持，并支付了神经成像和其他与研究相关的费用。通过Visualase公司的临床研究协议向埃默里大学提供资金，Visualase公司开发与本文所述研究相关的产品。这些资金帮助仅接受SLAH手术的患者支付与研究相关的费用。此外，格罗斯还担任Visualase的顾问，并从这些服务中获得了报酬。他还担任美敦力的顾问，美敦力是Visualase技术的当前所有者。埃默里大学根据其利益冲突政策审查和批准了这些安排的条款。格罗斯博士还从礼来公司、NeuroPace公司、圣裘德医疗公司、深脑创新公司和杜克大学获得咨询费。洛林报告从NeuroPace和Supernus获得咨询费，目前从PCORI和NIH获得赠款支持；从牛津大学出版社获得版税；在癫痫基金会的专业咨询委员会任职，并担任《癫痫》、《癫痫研究》和《神经心理学评论》的编辑委员会成员。他还接受与癫痫患者的神经心理评估有关的资金，包括WADA测试。
Dr. Drane has received three grants from the NIH/NINDS, which supported his work on the manuscript recently published in Epilepsia related to this letter to the editor response (K23 NSO49100, K02 NS070960, & R01NS088748). These grants provided salary support for Dr. Drane and his laboratory staff, and covered the cost of neuroimaging and other study related expenses. Funding was provided to Emory University by way of a clinical study agreement from Visualase, Inc., which develops products related to the research described in this paper. These funds assisted with the study-related costs of the patients undergoing the SLAH procedure only. In addition, Dr. Gross served as a consultant to Visualase and received compensation for those services. He also serves as a consultant to Medtronic, the current owner of the Visualase technology. The terms of there arrangements have been reviewed and approved by Emory University in accordance with its conflict of interest policies. Dr. Gross also receives consulting fees from Eli Lilly, Neuropace, St. Jude Medical Corp., Deep Brain Innovations, and Duke University.Dr. Loring reports receiving consulting fees from NeuroPace and Supernus and current grant support from PCORI and NIH; receives royalties from Oxford University Press; serves on the Professional Advisory Board for the Epilepsy Foundation, and sits on the editorial boards for Epilepsia, Epilepsy Research, and Neuropsychology Review. He also receives funds related to neuropsychological assessment of patients with epilepsy including Wada testing.
影响因子：
5.6
作者：
Drane DL;Loring DW;Voets NL;Price M;Ojemann JG;Willie JT;Saindane AM;Phatak V;Ivanisevic M;Millis S;Helmers SL;Miller JW;Meador KJ;Gross RE
通讯作者：
Gross RE